Skip to main content

Versant Vantage II, L.P.

In the past year, 1 open-market sale filing worth $10.4M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$10.4M
1 filing
Net
−$10.4M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Versant Vantage II, L.P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

LENZ LENZ Therapeutics, Inc.

10% Owner14 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 2, 2025 (view filing)4:40 PM ETSep 302 daysVersant Venture Capital VI, L.P. and 8 others10% OwnerSSale−132.9K$46.01−$6.12M−11.2%1.05M after3 lots
Oct 2, 2025 (view filing)4:40 PM ETSep 302 daysVersant Venture Capital VI, L.P. and 8 others10% OwnerSSale−92.0K$46.01−$4.23M−10.7%764.1K after3 lots
Sep 22, 2025 (view filing)4:23 PM ETSep 184 daysVersant Venture Capital VI, L.P. and 8 others10% OwnerSSale−90.7K$42.23−$3.83M−7.1%1.18M after3 lots
Sep 22, 2025 (view filing)4:23 PM ETSep 184 daysVersant Venture Capital VI, L.P. and 8 others10% OwnerSSale−44.6K$42.23−$1.89M−5.0%856.2K after3 lots
Aug 26, 2025 (view filing)7:59 PM ETAug 22-264 daysVersant Venture Capital VI, L.P. and 8 others10% OwnerSSale−126.0K$39.47−$4.97M−9.0%1.27M after6 lots
Aug 26, 2025 (view filing)7:59 PM ETAug 22-264 daysVersant Venture Capital VI, L.P. and 8 others10% OwnerSSale−62.1K$39.47−$2.45M−6.4%900.8K after6 lots
Aug 19, 2025 (view filing)4:51 PM ETAug 15-184 daysVersant Venture Capital VI, L.P. and 8 others10% OwnerSSale−175.7K$39.34−$6.91M−11.1%1.40M after2 lots
Aug 19, 2025 (view filing)4:51 PM ETAug 15-184 daysVersant Venture Capital VI, L.P. and 8 others10% OwnerSSale−85.0K$39.33−$3.34M−8.1%962.9K after2 lots
Jul 14, 2025 (view filing)4:50 PM ETJul 104 daysVersant Venture Capital VI, L.P. and 8 others10% OwnerSSale−191.4K$34.00−$6.51M−10.8%1.58M after
Jul 1, 2025 (view filing)6:16 PM ETJun 274 daysVersant Venture Capital VI, L.P. and 8 others10% OwnerSSale−200.0K$30.47−$6.09M−10.2%1.77M after

See all 14 trades at LENZ

TPST Tempest Therapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 12, 2024 (view filing)8:33 PM ETAug 8-124 daysVersant Ventures IV, LLC and 8 others10% OwnerSSale−788.0K$1.23−$967.0K−79.0%209.9K after2 lots

TSBX Turnstone Biologics Corp.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 27, 2023 (view filing)4:23 PM ETJul 252 daysVersant Affiliates Fund V, L.P. and 9 others10% OwnerPPurchase+225.0K$12.00+$2.70MNew position82.0K after4 lotsDuplicate filing

IPSC Century Therapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 11, 2022 (view filing)4:55 PM ETAug 92 daysVersant Venture Capital VI, L.P. and 5 others10% OwnerSSale−550.0K$13.03−$7.17M−4.4%11.8M after